64 search results for: Car-T Treatment

You are here: / Search results for "Car-T Treatment"

Results page

Search
Generic filters

64 search results for: Car-T Treatment

Sheba Medical Center and Swiss-based Lonza Pharma collaborate to enhance patient access to CAR T-cell immunotherapy

Sheba Medical Center and Swiss-based CDMO Lonza Pharma recently announced a new collaborative venture to use the cutting-edge CocoonTM manufacturing platform to develop point-of-care CAR T-cell therapy. This joint project aims to streamline the in-house cell manufacturing process, thereby enabling a greater amount of critically ill oncology patients to access genetically engineered human CAR T-cells more efficiently.

Pediatric Hemato-Oncology in Israel

The Pediatric Hemato-Oncology Department at Sheba Medical Center provides compassionate and comprehensive care for children with cancer and blood disorders, such as lymphomas and leukemias. Our internationally renowned specialists treat approximately 1,200 inpatients and 4,000 outpatients every year. As a part of the state-of-the-art Edmond and Lily Safra Children’s Hospital, we are committed to designing…

Swiss Life Sciences Company Lonza Opens New Center in Haifa

Lonza, a Swiss biotech company, opens their new Israeli Collaborative Innovation Center (CIC) in the Life Science Park, in Haifa. This Research & Development center features 1,000 square meters of space. CIC employs staff of 15 scientific professionals. Managed by Dr. Frida Grynspan-Gotlieb, the CIC aims to take advantage of Israel’s frontline expertise in software and cell/molecular biology and engineering in order to enhance Lonza’s capabilities.

Request a consultation